Chapman University

Chapman University Digital Commons
Biology, Chemistry, and Environmental Sciences
Faculty Articles and Research

Science and Technology Faculty Articles and
Research

9-4-2009

Broad Range Amino Acid Specificity of RNA-Dependent Lipid
Remodelling by Multiple Peptide Resistance Factors
Hervé Roy
The Ohio State University

Michael Ibba
Chapman University, ibba@chapman.edu

Follow this and additional works at: https://digitalcommons.chapman.edu/sees_articles
Part of the Amino Acids, Peptides, and Proteins Commons, Biochemistry Commons, Cellular and
Molecular Physiology Commons, Molecular Biology Commons, Nucleic Acids, Nucleotides, and
Nucleosides Commons, and the Other Biochemistry, Biophysics, and Structural Biology Commons

Recommended Citation
Roy, H. and Ibba, M. (2009) Broad range amino acid specificity of RNA-dependent lipid remodelling by
multiple peptide resistance factors. J. Biol. Chem. 284
284, 29677-29683. https://doi.org/10.1074/
jbc.M109.046367

This Article is brought to you for free and open access by the Science and Technology Faculty Articles and
Research at Chapman University Digital Commons. It has been accepted for inclusion in Biology, Chemistry, and
Environmental Sciences Faculty Articles and Research by an authorized administrator of Chapman University
Digital Commons. For more information, please contact laughtin@chapman.edu.

Broad Range Amino Acid Specificity of RNA-Dependent Lipid Remodelling by
Multiple Peptide Resistance Factors
Comments
This article was originally published in Journal of Biological Chemistry, volume 284, in 2009.
https://doi.org/10.1074/jbc.M109.046367

Copyright
American Society for Biochemistry and Molecular Biology

This article is available at Chapman University Digital Commons: https://digitalcommons.chapman.edu/
sees_articles/415

THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 284, NO. 43, pp. 29677–29683, October 23, 2009
© 2009 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.

Broad Range Amino Acid Specificity of RNA-dependent Lipid
Remodeling by Multiple Peptide Resistance Factors*
Received for publication, July 18, 2009, and in revised form, August 26, 2009 Published, JBC Papers in Press, September 4, 2009, DOI 10.1074/jbc.M109.046367
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Aminoacylphosphatidylglycerol synthases (aaPGSs) are multiple peptide resistance factors that transfer amino acids from
aminoacyl-tRNAs to phosphatidylglycerol (PG) in the cytoplasmic membrane. Aminoacylation of PG is used by bacteria to
decrease the net negative charge of the cell envelope, diminishing affinity for charged molecules and allowing for adaptation to
environmental changes. Lys-PGS, which transfers lysine to PG,
is essential for the virulence of certain pathogens, providing
resistance to both host cationic antimicrobial peptides and therapeutic antibiotics. Ala-PGS was also recently described, but
little is known about the possible activities of other members of
the highly diverse aaPGS family of proteins. Systematic deletion
of the predicted membrane-inserted domains of several aaPGSs
revealed that the carboxyl-terminal hydrophilic domain alone is
sufficient for aminoacylphosphatidylglycerol transferase catalytic activity. In contrast to previously characterized aaPGSs, the
Enterococcus faecium enzyme used an expanded repertoire of
amino acids to modify PG with Ala, Arg, or Lys. Reexamination
of previously characterized aaPGSs also revealed broader than
anticipated substrate specificity, for example Bacillus subtilis
Lys-PGS was shown to also catalyze Ala-PG synthesis. The
relaxed substrate specificities of these aaPGSs allows for more
elaborate remodeling of membrane lipids than previously
thought, potentially providing bacteria that harbor these
enzymes resistance to a broad spectrum of antibiotics and environmental stresses.

To adapt to changing environmental conditions, such as
those encountered during host infection, bacteria must alter
the properties of their cellular envelope by adjusting the composition and abundance of their membrane lipids. Bacteria
choose from a variety of lipid components that vary in fatty acid
chain length and saturation levels and that bear a repertoire of
different polar head groups. Aminoacylphosphatidylglycerol
synthases (aaPGSs)2 are enzymes embedded within the bacterial membrane that are responsible for the transfer of amino
acids from aminoacyl-tRNAs (aa-tRNAs) to the polar head
groups of phosphatidylglycerol (PG). Addition of amino acids
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to membrane PG is a critical mechanism evolved by bacteria to
decrease the net negative charge of the cell membrane (1). This
alteration of charge diminishes the membrane affinity for cationic antimicrobial peptides used by the host immune system
(i.e. defensins), and for other bactericidal agents (2). During
infection, aaPGSs have been shown to be essential for the virulence of several pathogenic microorganisms by facilitating the
evasion of antibiotic activity. Their role in virulence and their
broad distribution in bacterial species make aaPGSs attractive
targets for new therapeutic strategies to combat pathogenic
microbes.
Lys-PG in the membrane allows for the evasion of neutrophils and enhances the virulence of Staphylococcus aureus both
in mice (3) and in endovascular infection of rabbits (4). Similar
observations were made for Listeria monocytogenes, in which
Lys-PG enhances infectivity of epithelial cells and macrophages
in mice (5, 6). Moreover, Lys-PG provides S. aureus with resistance to other classes of cationic bactericidal agents such as vancomycin (glycopeptide) and daptomycin (lipopeptide) (7, 8),
which are often used as a last resort to treat infections. A new
aaPGS with altered specificity was recently discovered in Clostridium perfringens and Pseudomonas aeruginosa (9, 10). This
enzyme, Ala-PGS, is responsible for the formation of Ala-PG in
the membrane. Despite the net neutral charge of Ala-PG, this
modification has been shown to enhance bacterial resistance to
certain cationic antimicrobial peptides (10). Both Lys-PG and
Ala-PG have also been shown to enhance the resistance of S.
aureus and P. aeruginosa to several negatively charged ␤-lactams (e.g. oxacillin, methicillin, cefsulodin) (7, 10, 11). These
latter findings suggest that aaPGs confer antibiotic resistance
both by diminishing the net negative charge of the membrane
and by modulating more general biophysical properties such as
membrane fluidity and permeability (12). In addition, aaPGs
not only decrease membrane permeability to cationic antimicrobial peptides, but also to protons and osmolytes (e.g. lactate),
providing bacteria with resistance to challenging osmotic or
acidic growth conditions such as those encountered during fermentative growth (10, 13, 14).
Despite recent progress, many questions remain unanswered
concerning PG aminoacylation in bacteria. Since the identification of Lys-PGS and Ala-PGS and the discovery of resistances
associated with these enzymes the amino acid specificities of
only seven aaPGSs have been directly characterized (2, 5, 9, 10,
13, 15–18). Predicted aaPGS sequences from different organisms display a remarkable level of secondary structural diversity. To date, 348 putative aaPGS genes in 213 distinct species
have been identified in 96 different genera of microorganisms,
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covering almost all known groups of bacteria. Also, 49 of the
available genome sequences encode two or more aaPGS paralogs. This dual occurrence is most often encountered in Grampositive bacteria, particularly in members of the Actinobacteria class (e.g. Mycobacterium, Streptomyces, etc.). Here, we
describe structure/function-based assignment of aaPGS catalytic domains that subsequently allowed us to identify new
amino acid specificities of PG aminoacylation. The coexistence
of several such activities in the same organism expands the set
of unique aaPGSs that are available for tuning of membrane
properties and may provide these bacteria with resistance to a
far broader spectrum of antimicrobial agents and environmental conditions than previously appreciated. In addition, our
work shows that although some aaPGSs display strict substrate
specificity (e.g. Lys-PGS from C. perfringens), some aaPGSs display relaxed substrate specificity in vitro. For example, Enterococcus faecium aaPGS exhibits a triple specificity for Ala-, Arg-,
and Lys-tRNA, and Bacillus subtilis displays a dual specificity
for Lys- and, Ala-tRNA.

EXPERIMENTAL PROCEDURES
Strains, Plasmids, and General Methods—The open reading
frames encoding the aaPGSs from E. faecium DO (gi: 69245409
and 69249189) and Agrobacterium tumefaciens (gi: 15889786)
were amplified by PCR and cloned under the control of the T7
promoter at the NcoI/XhoI restriction sites of the vector pet33b
(kanR; Novagen). The same vector was previously used for the
cloning of the aaPGSs from B. subtilis and C. perfringens (9, 15).
Recombinant vectors were used to transform the Escherichia
coli strain C41 DE3 containing the plasmid pRARE2 (camR;
Novagen) expressing tRNAs for translation of rare codons.
Protein production was performed according to procedures
described before (15) in autoinduction medium incubated
overnight at 30 °C under agitation. To remove the membrane
domain of aaPGSs partially or totally, site-directed mutagenesis
was performed with the QuikChange kit (Stratagene) according
to the manufacturer’s instructions. Affinity-tagged lysyl-tRNA
synthetase (Lys-RS) and alanyl-tRNA synthetase (Ala-RS) from
E. coli and arginyl-tRNA synthetase (Arg-RS) from jack bean
were produced and purified according to procedures described
previously (19 –21).
Membrane Extracts and Lipid Analysis—Membrane suspensions from aaPGS-expressing strains were prepared by successive centrifugation steps. Briefly, the cells were disrupted by
sonication in a buffer containing 50 mM Tris-HCl, pH 8.0, 1 mM
diisopropylfluorophosphate, 1 mM phenylmethylsulfonyl fluoride, 3 mM 2-mercaptoethanol. Cell debris were removed by
centrifugation for 15 min at 10,000 ⫻ g. Membranes were sedimented from the supernatant by ultracentrifugation for 45 min
at 250,000 ⫻ g. Membrane suspension was obtained after gentle
sonication of the pellet and was then stored at ⫺80 °C in the
lysis buffer containing 20% glycerol. The concentration of protein in the membrane suspension was 15–20 mg/ml, as measured by the method of Bradford (Bio-Rad). Total lipids were
extracted from cells using the procedure of Bligh and Dyer (22)
with 120 mM potassium acetate, pH 4.5, in the aqueous phase.
Lipids were analyzed by TLC on Silica Gel HL plates (Analtech)
developed in one dimension or two dimensions by using, suc-
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cessively, the solvents chloroform:methanol:water (14:6:1, vol/
vol/vol) in the first dimension and chloroform:methanol:acetic
acid (13:5:2, vol/vol/vol) in the second dimension. Lipids were
visualized by fluorescence after staining with primuline.
tRNA-dependent AaPG Synthesis—aaPGS activity within the
membrane suspensions obtained from aaPGS-producing
strains was assayed in a reaction medium containing 100 mM
Hepes-NaOH, pH 7.2, 30 mM KCl, and 15 mM MgCl2, 8 mM
ATP, 2 mg/ml total tRNA from E. coli MRE 600 (Roche Applied
Science), 20 M 14C-labeled amino acids, 1 M appropriate aminoacyl-tRNA synthetase, 3.25 mg/ml membrane extract, and a
2 mg/ml suspension of egg-PG (Avanti) prepared as described.
After 30 min of incubation at 37 °C, lipids were extracted by the
Bligh and Dyer procedure (22), dried, and resuspended in 20 l
of a solution of chloroform:methanol (2:1). 2 l of the extract
was then subjected to analysis by TLC (see above). Transcripts
of tRNAArg from jack bean and tRNALys UUU from E. faecium
were synthesized as previously described, and used in the aaPG
biosynthesis assay in the presence of E. coli Lys-RS or jack bean
Arg-RS, respectively.
Alignment and Phylogenetic Analysis—Sequences were
retrieved by Blast (23) using the Lys-PGS from B. subtilis as a
template. 437 aaPGS sequences displaying an E value ⬍ 10E-6
were aligned using ClustalX 2.0 (24). The alignment was split
according to the three different domains present in aaPGSs
(membrane, hydrophilic, and Lys-RS domains), and the sequences were independently realigned. Phylogenetic analyses
were conducted with the Phylip package 3.68 with a representative subset of 230 sequences displaying ⬍95% identity. The
tree was constructed from a bootstrap of 100 replicates of a
degapped alignment of 218 residues using the neighbor-joining
method. A consensus tree was edited with iTOL (25). Prediction of transmembrane helices in aaPGSs was performed using
TMHMM (26) and TOPCONS (27).

RESULTS
E. faecium Possesses a Dual-specificity Arg/Lys-PGS—Previous reports describe the presence of several amino acids associated with phosphatidylglycerol in the membrane of E. faecium (formerly Streptococcus faecalis) (28). These studies
showed that Lys-PG is present, along with significant amounts
of Arg-PG, in the membrane of this organism, suggesting the
possible presence of two distinct aaPGSs responsible for the
biosynthesis of these two aaPGs. The presence of two aaPGS
paralogs responsible for the biosynthesis of two distinct aaPGs
(Lys-PG and Ala-PG) has recently been reported in C. perfringens (9). Using B. subtilis Lys-PGS as a guide, BLAST search
analyses of the publicly available genome sequences of E. faecium (E. faecium DO, TX1330, 1141733, 1231501, Com12, and
Com15) revealed the presence of two aaPGS paralogs encoded
in all six organisms. Both open reading frames (aaPGS1 and
aaPGS2, accession numbers ZP_00603404 and ZP_00604896,
respectively) from E. faecium DO were cloned in pet33b and
expressed in E. coli. The aaPGS activities of membrane extracts
from the producing strains were tested with Lys-tRNALys and
Arg-tRNAArg as aminoacyl group donors. This analysis failed to
reconstitute the activity of aaPGS1 but showed unambiguously
the dual aa-tRNA specificity (Lys/Arg) of aaPGS2 (Fig. 1).
VOLUME 284 • NUMBER 43 • OCTOBER 23, 2009
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FIGURE 1. Activity of aaPGS2 from E. faecium. AaPGS activities in the membrane fraction of the E. coli strain C41 transformed with the vector pet33b
empty (C41-pet) or producing aaPGS2 from E. faecium (C41-Efa2) were
assayed as described under Experimental Procedures in the presence of
[14C]Lys (K) or [14C]Arg (R).

These results suggest that the presence of Arg-PG and Lys-PG
in the membrane of E. faecium may be due to a single aaPGS
that bears two aa-tRNA specificities. Further in vitro characterization of these activities with tRNA transcripts (i.e. tRNALys
UUU from E. faecium and tRNAArg from jack bean) revealed
that aaPGS2 displays a specific activity for lysylation of PG only
6.5-fold higher than that for arginylation. This result prompted
us to reinvestigate the specificities of known aaPGSs using an
expanded range of aa-tRNAs and to determine the specificity of
a previously uncharacterized aaPGS.
AaPGSs Display Divergent Specificity for Aa-tRNAs in Vitro—
The specificities of the Lys-PGS from B. subtilis and of the AlaPGS from C. perfringens have been determined previously (9,
18) and were now reinvestigated using Lys-, Arg- and Ala-tRNA
as substrates. An aaPGS homologous to Lys-PGS has also been
reported in the Rhizobiales (i.e. Sinorhizobium medicae) for
which it conferred resistance to lethal acidic conditions (14).
However, the function of aaPGS in Rhizobiales remained
unclear because no Lys-PG was detected (14). These previous
results prompted us also to characterize the substrate specificity of a Rhizobiales aaPGS, in this case from the plant pathogen
A. tumefaciens. All aaPGSs tested displayed activity in vivo (Fig.
2) and a moderate specificity toward their aa-tRNAs. For example, the B. subtilis enzyme, previously reported as a Lys-PGS,
was also able to synthesize Ala-PG, but Arg-PG was not
detected in this case (Fig. 2B). A. tumefaciens aaPGS synthesized Lys-PG, but no trace amounts of either Arg-PG or Ala-PG
could be detected when this enzyme was assayed with AlatRNAAla and Arg-tRNAArg (Fig. 2C). Although the B. subtilis
aaPGS displayed relaxed substrate specificity, Ala-PGS from C.
perfringens exhibited a more stringent specificity for AlatRNAAla because neither Lys-PG nor Arg-PG was synthesized
by this enzyme (Fig. 2D). Reexamination of E. faecalis aaPGS2
revealed that it was able to make Ala-PG in addition to Arg-PG
OCTOBER 23, 2009 • VOLUME 284 • NUMBER 43

FIGURE 2. Specificity of aaPGSs from various origins. Membrane extracts
from the E. coli strain C41 containing the empty vector pet33b (C41-pet; A) or
producing the aaPGS from B. subtilis (C41-bsu; B), A. tumefaciens (C41-Atu; C);
C. perfringens (C41-Cpe; D); or E. faecium (C41-Efa2; E). Activities were assayed
as described under Experimental Procedures in the presence of [14C]Lys (K),
[14C]Arg (R), or [14C]Ala (A).

and Lys-PG (Fig. 2E). Our findings show that known aaPGSs fall
into three categories according to their specificities: (i) aaPGSs
that display a single, strict, specificity (e.g. Ala-PGS from C.
perfringens and Lys-PGS from A. tumefaciens) and produce no
detectable traces of other aaPGs; (ii) aaPGSs with a “primary”
specificity (i.e. Lys-PGS from B. subtilis) that are also capable of
producing several other aaPGs less efficiently; and (iii) aaPGS
with relaxed specificity (Ala/Arg/Lys-PGS from E. faecium)
able to synthesize several aaPGs at comparable levels.
AaPGS Structural Heterogeneity—To correlate the divergent
specificity of aaPGSs with structural features, 230 representative sequences from 204 organisms were aligned and compared
(Fig. 3). AaPGSs are predicted to be composed of a membraneinserted amino terminus appended to a hydrophilic carboxyl
terminus, but the precise role of each of these domains is
unknown. The membrane domain varies in size and in
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 3. Phylogeny and modular organization of aaPGSs. Aa-tRNA specificity of the aaPGSs that have been characterized in vitro is indicated (black arrow).
The modular organization and number of predicted helices within the integral membrane domain of each sequence, respectively, are reported beside each
named organism and by a colored background. Branches displaying a bootstrap support ⬎80% are indicated by gray circles. The number of aaPGS paralogs
within a given organism is indicated in brackets.

sequence and is even absent from aaPGS homologs in a few
cases (e.g. Streptomyces, Burkholderia). Based on the predicted
secondary structure, the membrane-inserted domain is
thought to consist of a variable number of ␣-helices (4 to 14)
that orient the amino-terminal extremity and direct the hydrophilic carboxyl-terminal moiety toward the cytoplasm where
aa-tRNAs, the substrate of aaPGSs, are synthesized. Biochemi-
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cally characterized aaPGSs possess a membrane domain containing 14 predicted ␣-helices, except for the Ala-PGS from C.
perfringens that contains only six helices. More distant aaPGS,
such as the paralogs found in actinomycetes, are fused with a
Lys-RS domain that displays 40% identity with E. coli Lys-RS.
This domain exhibits all of the features associated with tRNA
lysylation such as a tRNA anticodon binding domain (OB-fold)
VOLUME 284 • NUMBER 43 • OCTOBER 23, 2009
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along with all the conserved positions in Lys-RSs necessary for
substrate binding (Lys, ATP, and tRNA) and enzyme dimerization (data not shown). The presence of this domain in aaPGS is
probably involved in the channeling of the Lys-tRNA toward
the membrane modification site. However, these enzymes possess a notably shorter membrane domain, containing six transmembrane ␣-helices. These secondary structural comparisons
suggest that the aaPGS active site is likely located within the
hydrophilic carboxyl-terminal moiety of the polypeptide.
AaPGSs Contain a Catalytic Carboxyl-terminal Domain—
To determine whether the membrane-inserted domain of
aaPGS plays a role in catalysis, the amino termini of the C.
perfringens Ala-PGS and of the B. subtilis Lys-PGS were truncated to leave either one or none of the hydrophobic helices
intact. It is worth noting that these predicted membrane
domains are quite divergent: B. subtilis Lys-PGS contains14
helices whereas C. perfringens Ala-PGS contains only 6. The
activity of the different constructs was then investigated in vivo
and in vitro. Although the presence of a single helix resulted in
little or no activity in vitro, removal of the entire membrane
domain led to variants with significant activity, indicating that
aaPG synthesis is catalyzed by the hydrophilic amino terminus
alone (Fig. 4). In contrast, only the full-length aaPGSs, but none
of the truncated variants, displayed aaPG synthetic activity in
vivo (Fig. 5).

DISCUSSION
Distinct Roles of the AaPGS Amino- and Carboxyl-terminal
Domains—Recent studies of aaPGSs, particularly in the context
of drug-resistant mprF alleles, provided preliminary indications
of the possible roles of different domains of the protein. For
example, loss of daptomycin susceptibility allowed the tentative
assignment of lysyl-PG translocase (flippase) activity to the
N-terminal eight transmembrane helices of S. aureus Lys-PGS
(29, 30). It was also proposed that the synthase domain consisted of six transmembrane helices appended to the carboxyl
terminus. Our data now show that the carboxyl terminus alone
is sufficient for full synthase activity in vitro. The absence of
activity in vivo for the carboxyl-terminal domain alone suggests
that transmembrane helices position the catalytic domain in
the cytosol during aaPG synthesis. The dual role of the membrane-inserted amino terminus, both as a translocase and for
anchoring the catalytic moiety, is consistent with the high
degree of heterogeneity observed in this region compared with
the more conserved carboxyl terminus (Fig. 3). AaPGSs are
encoded in many phylogenetically distant bacteria, and divergence in the membrane-inserted domain may reflect adaptation to a wide range of cell wall morphologies and lipid compositions. The carboxyl-terminal catalytic domain instead
recognizes molecules that show relatively little phylogenetic
variation, aa-tRNAs, consistent with the higher degree of conservation seen within this domain across different species.
Aa-tRNA Selection by AaPGS—Pioneering studies in S.
aureus first identified lysyl-tRNA-dependent PG modification
by Lys-PGS as a means to increase the net positive surface
charge of bacteria (2, 31). More recently, tRNA-dependent
Ala-PG synthesis was also demonstrated (9), thereby establishing that the aaPGS family does not exclusively catalyze lipid
OCTOBER 23, 2009 • VOLUME 284 • NUMBER 43

FIGURE 4. Activity of truncated aaPGSs. A, schematic representation of the
B. subtilis (Bsu) and C. perfringens (Cpe) aaPGSs. Truncation within the aminoterminal membrane domain of both proteins is indicated. The membrane
domains of B. subtilis and C. perfringens aaPGSs contain 14 and 6 ␣-helices,
respectively (as predicted by TOPCONS). B, aaPGS activity of full-length and
truncated proteins. Membrane extracts were tested as described under
Experimental Procedures with the corresponding 14C-labeled aa-tRNA in a
medium containing 14C-labeled amino acids, ATP, total tRNA from E. coli, and
the cognate aa-RS.

lysylation. Both Arg and ornithine would be expected to have an
impact on the charge of PG comparable with Lys, and both
Arg-PG and ornithyl-PG have previously been identified in
bacteria (for review, see 32). Although tRNA-dependent ornithyl-PG synthesis could not be detected,3 Arg-PG and Ala-PG
synthase activities were readily observed for some Lys-PGs
tested. The triple specific Ala/Arg/Lys-PGS from E. faecium
displayed the broadest specificity because this enzyme was also
able to synthesize Ala-PG at an efficiency comparable with Argor Lys-PG. These data suggest that aaPGSs capable of transferring bulkier amino acids such as Lys or Arg may display a moderate specificity compared with those that utilize smaller amino
acids such as Ala. These observations imply that aaPGSs
adapted to bind smaller amino acids (i.e. Ala) cannot accom3

H. Roy and M. Ibba, unpublished results.
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